Banque Pictet & Cie SA lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 13.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 43,823 shares of the medical equipment provider’s stock after selling 6,604 shares during the period. Banque Pictet & Cie SA’s holdings in Intuitive Surgical were worth $22,874,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the stock. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management boosted its holdings in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have weighed in on ISRG. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Mizuho increased their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Barclays raised their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Leerink Partners upped their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.
Insider Buying and Selling at Intuitive Surgical
In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Stock Performance
ISRG stock opened at $591.39 on Friday. The stock has a market capitalization of $210.64 billion, a P/E ratio of 92.26, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a 50 day moving average price of $557.70 and a two-hundred day moving average price of $517.49.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Stock Sentiment Analysis: How it Works
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- ETF Screener: Uses and Step-by-Step Guide
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- What Is WallStreetBets and What Stocks Are They Targeting?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.